Patrick Martin
BioAge Labs, Inc. · Nalu Medical, Inc. · Nalu Medical
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patrick Martin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:25 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06141889 · Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy VolunteersBioAge Labs, Inc. · completed · Healthy Volunteer Study · study director
- N/ANCT05870124 · Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)Nalu Medical, Inc. · active not recruiting · Peripheral Neuralgia, Peripheral Neuropathy, Chronic Pain · study director
- N/ANCT05287373 · Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic PainNalu Medical, Inc. · active not recruiting · Peripheral Neuralgia, Chronic Pain · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:25 UTC. The ranking covers the 200 most relevant of 545 PubMed records, and a shared surname and initials can bring in a namesake. All 545 on PubMed
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med · 20184,679 citationsRCR 163.2
- Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.N Engl J Med · 20131,386 citationsRCR 35.6
- Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.N Engl J Med · 19891,199 citationsRCR 40.6
- PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.N Engl J Med · 2014894 citationsRCR 24.0
- Neonatal abstinence syndrome after methadone or buprenorphine exposure.N Engl J Med · 2010701 citationsRCR 26.5
- Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.JAMA Intern Med · 2014498 citationsRCR 23.7
- 413 citationsRCR 12.3
- Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.J Clin Oncol · 2023345 citationsRCR 28.7
- Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.Gastroenterology · 2006312 citationsRCR 8.4
- 309 citationsRCR 19.2